跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,665 条关于
“Intas Pharma”
全部
9,665
临床试验
4,100
药物
1,132
机构
1,224
资讯
3,209
去年
Intas Pharma Receives CDSCO Panel Nod for Aflibercept Biosimilar DME Trial
去年
Intas Pharmaceuticals Receives CDSCO Panel Approval for Phase III Trial of R-hFSH
去年
Intas Pharmaceuticals and Accord BioPharma Acquire UDENYCA Biosimilar, Expanding Global Pegfilgrastim Market Presence
去年
Intas Pharma Receives CDSCO Panel Approval for Phase III Trial of Ruxolitinib Cream
8个月前
Intas Pharmaceuticals Partners with IntegriMedical to Launch India's First Needle-Free IVF Injection System
2年前
Accord BioPharma's Ustekinumab Biosimilar BLA Accepted by FDA, Launch Expected by May 2025
去年
Imuldosa (Ustekinumab-srlf) Receives FDA Approval as Stelara Biosimilar
去年
Indian Pharma Companies Advance Semaglutide Development as CDSCO Approves Clinical Trial Protocols
5个月前
Bio-Thera Solutions Expands Partnership with Intas for Golimumab Biosimilar BAT2506 in India
去年
CHMP Recommends Approval of Henlius and Intas' Serplulimab for ES-SCLC in Europe
第 1 页,共 321 页
上一页
下一页